Case Report: Successful Treatment of Pediatric Alopecia Universalis with Ritlecitinib After Failure of Baricitinib

This case report discusses a pediatric patient with alopecia universalis who experienced successful treatment with ritlecitinib after baricitinib failed. Alopecia areata in children is challenging to treat and often recurs, causing significant distress. Current treatments have limited efficacy and many side effects. This is the first documented case of a child transitioning from baricitinib to ritlecitinib, leading to positive clinical outcomes, marking a significant advancement in treating chronic severe alopecia areata in children.